Skip to main content
. 2022 Aug 9;38(1):1–11. doi: 10.1093/arclin/acac068

Table 1.

Sociodemographic data and relevant medical history

Total sample
n = 121
Mild subgroup
n = 49
Moderate subgroup
n = 48
Severe subgroup
n = 24
Mean age in years (± SD)
[range]
56.69 (± 10.41)
[35–78]
54.86 (± 8.78)
[35–71]
55.85 (± 10.40)
[36–75]
62.08 (± 12.03)
[38–78]
Mean education level [1–3]aSD) 2.65 (± 0.54) 2.76 (± 0.43) 2.63 (± 0.61) 2.50 (± 0.59)
Sex (% woman) 32.23 34.69 35.42 20.83
Mean days of hospitalization (± SD) 11.89 (± 11.89) 40.13 (± 32.07)
Mean days between infection and assessment (± SD) 222.46 (± 42.93) 215.98 (± 35.79) 223.65 (± 50.50) 233.04 (± 38.69)
Diabetes (%) 8.26 2.04 8.33 20.83
Smoking (%) 6.61 12.24 2.08 4.20
History of respiratory disorders (%) 14.88 12.24 12.50 25.00
History of cardiovascular disorders (%) 16.53 12.24 16.67 25.00
History of neurological disorders (%) 0 0 0 0
History of psychiatric disorders (%) 3.31 4.08 2.08 4.20
History of cancer (%) 0 0 0 0
History of severe immunosuppression (%) 0 0 0 0
History of developmental disorders (%) 0 0 0 0
Chronic renal failure (%) 1.65 0 0 8.30
Sleep apnea syndrome (%) 14.88 8.16 14.58 29.20

Note. Mild: patients not hospitalized for SARS-CoV-2 infection; Moderate: patients hospitalized without mechanical ventilation for SARS-CoV-2 infection; ns: not significant; Severe: patients hospitalized in intensive care with mechanical ventilation for SARS-CoV-2 infection; SD: standard deviation.

aLevel 1 is equivalent to the compulsory Swiss scholarship (<11 years of study); level 2 is equivalent to a vocational diploma (11–12 years of study); and level 3 is equivalent to Matura level and higher education (>12 years of study).